Form 8-K
8-K — TOMI Environmental Solutions, Inc.
Accession: 0001654954-26-007621
Filed: 2026-08-14
Period: 2026-08-14
CIK: 0000314227
SIC: 2860 (INDUSTRIAL ORGANIC CHEMICALS)
Item: Results of Operations and Financial Condition
Item: Financial Statements and Exhibits
Documents
8-K — tomz_8k.htm (Primary)
EX-99.1 — PRESS RELEASE (tomz_ex991.htm)
GRAPHIC (tomz_ex991img1.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — FORM 8-K
8-K (Primary)
Filename: tomz_8k.htm · Sequence: 1
tomz_8k.htm
0000314227false00003142272026-08-142026-08-14iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 14, 2026
TOMI ENVIRONMENTAL SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
Florida
000-09908
59-1947988
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
8430 Spires Way
Frederick, Maryland 21701
(Address of principal executive offices) (Zip Code)
(800) 525-1698
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
TOMZ
Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On August 14, 2026, TOMI Environmental Solutions, Inc. issued a press release regarding its financial results for the second quarter ended June 30, 2026. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1. No additional information is included in this Current Report on Form 8-K.
The information included in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed “filed” for purposes of, nor shall it be deemed incorporated by reference in, any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
See the Exhibit Index below, which is incorporated by reference herein.
Exhibit No.
Description
99.1
Press Release date August 14, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TOMI ENVIRONMENTAL SOLUTIONS, INC.
Date: August 14, 2026
By:
/s/ Halden S. Shane
Name: Halden S. Shane
Title: Chief Executive Officer
3
EX-99.1 — PRESS RELEASE
EX-99.1
Filename: tomz_ex991.htm · Sequence: 2
tomz_ex991.htm
EXHIBIT 99.1
FOR IMMEDIATE RELEASE
TOMI Environmental Solutions, Inc. Reports
Second Quarter 2026 Financial Results
Company Delivers 118% Q2 Revenue Growth,
Reaffirms Full-Year 2026 Guidance of $12 Million (113% YoY Growth)
FREDERICK, Md., August 14, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today announced financial results for the three and six months ended June 30, 2026, and provided an update on strategic initiatives.
Select financial and operational achievements for the quarter are as follows:
·
Q2 Revenue Surges 118% Year-Over-Year to $2.25 Million; Sequential Revenue Increases 36% Over Q1 2026
·
Gross Profit More Than Doubles to $1.39 Million; Gross Margin Improves to 61.7% from 50.3% in Q1 2026
·
Reaffirms Full-Year 2026 Revenue Guidance of at Least $12.0 Million
·
Definitive Merger Agreement Signed with Carbonium Core
·
Secures Unconditional EPA Registration for SteraMist® (BIT®) – AgriMist across Post-Harvest Agriculture, Cannabis and Hemp
·
Expands European Regulatory Footprint to 11 Countries; Advances NSF Certification Framework for Biosafety Cabinets
Executive Commentary
Dr. Halden Shane, CEO of TOMI Environmental Solutions commented, “The second quarter of 2026 was a defining operational and commercial period for TOMI, delivering our third consecutive quarter of accelerating growth, with year-over-year revenue growth of 118% to $2,247,000. Gross profit roughly doubled, and with strict cost control, the Company continues to work toward operating at breakeven on a cash basis. We are very proud of these achievements. We believe this performance reflects strong execution across our razor-and-blade commercial model, driven by surge demand for capital equipment, Custom Engineered Systems, and rapid adoption of our SteraMist applicators.”
1
“From a strategic and technical perspective, we also made excellent progress. We made critical advances across our technical, regulatory, and commercial pipelines. In the second quarter, we delivered custom SteraMist iHP chambers to a Fortune 500 medical device manufacturer—advancing our formal FDA 510(k) clearance process—while expanding our commercial sales pipeline to approximately $35 million ($8.6 million in advanced stages) and growing our backlog to $2.6 million post-quarter.”
“On the regulatory front, our biocidal product registrations now span 11 European countries, and the EPA recently granted a new unconditional registration for AgriMist (-4 label), authorizing direct SteraMist application through the day of harvest across food safety, cannabis, and agriculture. We are excited for the future of TOMI and look forward to providing additional updates in the near term”
Q2 2026 Highlights:
·
Significant Revenue Acceleration: Q2 2026 revenue of $2,246,909 represented a 118% increase year-over-year versus Q2 2025 ($1,031,115) and a 36% sequential increase over Q1 2026 ($1,654,227), reflecting strong commercial momentum across mobile capital equipment and Custom Engineered System (CES) deployments. Six-month year-to-date revenue expanded 50% to $3,901,000 compared to $2,608,000 in the prior-year period.
·
Strong Gross Profit: Gross profit more than doubled, increasing 105% to $1,385,306 compared to $677,124 in Q2 2025 and increasing 67% sequentially from $831,776 in Q1 2026, reflecting strong revenue growth and continued expansion of the Company's equipment, consumable, and service businesses.
·
Strong Margin Profile: Gross margin improved to 61.7% for Q2 2026 from 50.3% in Q1 2026 and remained at a healthy level compared to 65.7% in Q2 2025, driven by strong equipment sales, higher revenue volume, and continued growth in consumable and recurring revenue streams.
·
Applicator & Consumable Growth: Q2 2026 applicator sales reached $355,000 (up from $13,000 in Q2 2025), validating growing customer adoption of our razor-and-blade business model. Mid-year BIT™ Solution consumable sales exceeded $700,000, continuing to build a high-margin recurring revenue stream.
·
Substantial Improvement in Operating Performance: Operating loss for Q2 2026 improved 78% to $(244,142) compared to $(1,132,689) in Q2 2025, demonstrating significant progress toward operating breakeven. Net loss for the second quarter of 2026 improved 69% to $(382,299), or $(0.05) per basic and diluted share, compared to $(1,237,516), or $(0.19) per basic and diluted share, for the second quarter of 2025. For the six-month period, net loss improved 20% to $(1,192,945) compared to $(1,493,109) in the prior-year period.
2
·
Disciplined Cost Overhead: Total operating expenses for Q2 2026 declined 10% year-over-year to $1,629,448 (versus $1,810,000 in Q2 2025), reflecting sustained overhead discipline across general, administrative, and selling costs while continuing to invest in core business development.
·
Strengthened Balance Sheet & Liquidity: Cash and cash equivalents reached $321,899 as of June 30, 2026, up from $87,775 at December 31, 2025. Shareholders’ equity improved significantly to $1,428,436 (up from $588,504 at year-end 2025), while working capital increased to $1,818,000 (up from $1,024,000 at year-end 2025), further strengthening liquidity and operational flexibility.
·
Expanding Backlog & High-Value Sales Pipeline: Total sales order backlog expanded to $2.2 million as of June 30, 2026 (and has since increased to $2.6 million post-quarter). Booked orders and expected completions before year-end exceed $6.2 million, supporting an active integrated project pipeline (SIS, Hybrid, and CES) of $4.3 million across 13 projects and an overall commercial sales pipeline of approximately $35 million ($8.6 million in advanced stages).
Financial Results for the three and six months ended June 30, 2026, compared to June 30, 2025
·
Sales, net was $2,246,909 compared to $1,031,115 for the three months ended June 30, 2026, and 2025, respectively, a 118% increase. Product revenue increased $1,205,000 (185%) to $1,858,000, driven by surge demand for capital equipment, Custom Engineered Systems (CES), and targeted SteraMist applicator adoption. Service revenue increased $11,000 (3%) to $389,000, supported by growing service provider rental activity and recurring decontamination service contracts.
·
Geographic Performance: Domestic (U.S.) revenue increased 132% to $1,908,000 compared to $822,000 in Q2 2025. International revenue grew 62% to $339,000 compared to $209,000 in Q2 2025, supported by the onboarding of new customers in the UK.
·
Gross Profit was $1,385,306, or 61.7% of net sales, for Q2 2026, compared to $677,124, or 65.7% of net sales, for Q2 2025. Gross profit increased 105% year-over-year and 67% sequentially from $831,776 in Q1 2026. The Company maintained a strong margin profile while benefiting from increased revenue volume, equipment sales, and continued growth in consumable and recurring service revenue.
3
·
Total operating expenses were $1,629,448 for Q2 2026, a reduction of $180,365 or 10% compared to $1,809,813 in Q2 2025, reflecting disciplined overhead management and lower general and administrative costs, partially offset by increased professional and consulting expenses associated with strategic growth initiatives.
·
Loss from operations was $(244,142) for Q2 2026, an improvement of $888,547 (78%) compared to $(1,132,689) for Q2 2025, demonstrating significant progress toward operating breakeven.
·
Net loss was $(382,299), or $(0.05) per basic and diluted share for Q2 2026, compared to a net loss of $(1,237,516) or $(0.19) per basic and diluted share for Q2 2025.
·
Sales order backlog stood at $2.2 million as of June 30, 2026 (expanding to $2.6 million post-quarter), supporting an active integrated project pipeline (SIS, Hybrid, and CES) of $4.3 million across 13 projects and providing strong visibility into second-half revenue conversion.
Recent Business Highlights:
·
On April 27, 2026, the Company reported strong interest in its solutions at INTERPHEX 2026, engaging with over 200 current and potential customers and finalizing timelines with a prominent American healthcare company to develop an iHP integration for its proprietary premix container system.
·
On April 29, 2026, the Company announced a major strategic pivot toward autonomous systems, targeting drone-enabled, robotic, and AI-powered SteraMist iHP decontamination across global transportation, defense, aviation, and maritime platforms.
·
On April 30, 2026, the Company executed a non-binding letter of intent to merge with Carbonium Core, Inc., a U.S.-based producer of nuclear-grade graphite for advanced reactor technologies, with an implied enterprise valuation of $120 million.
·
On May 7, 2026, the Company's Binary Ionization Technology received formal approval from four additional European Union member states, expanding total EU and UK regulatory authorizations to eleven countries.
·
On May 27, 2026, the Company highlighted expanded commercial relevance for SteraMist amid rising global concerns tied to a CDC-published hantavirus study and escalating Ebola outbreak activity.
·
On June 29, 2026, the Company signed a definitive Agreement and Plan of Merger with Carbonium Core, Inc., pursuant to which Carbonium stockholders will receive 19.99% of TOMZ common stock at closing plus Series C Preferred Stock convertible into 90% of the combined company upon shareholder approval, supported by a required $10 million concurrent financing transaction.
4
·
On July 20, 2026, post-quarter, the Company effected a 1-for-3 reverse stock split of its Common Stock and Series A Preferred Stock to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
·
On August 3, 2026, post-quarter, the U.S. Environmental Protection Agency granted a new unconditional registration for SteraMist® (BIT®) – AgriMist (EPA Reg. No. 90150-4), expanding labeled use sites to include post-harvest food safety applications, cannabis and hemp cultivation, and greenhouse agriculture up to and including the day of harvest.
Looking Ahead
TOMI enters the second half of 2026 with strong commercial visibility, an expanding recurring revenue base, and a proposed corporate merger under way. The Company is executing a focused strategy to:
·
Advance Proposed Merger: Complete the required $10 million concurrent financing and advance toward closing the definitive merger with Carbonium Core, Inc., subject to regulatory and stockholder approvals.
·
Drive Recurring Revenue: Accelerate year-over-year recurring revenue through increased BIT™ Solution sales, expanding applicator adoption, and growing iHP Corporate Service contracts across healthcare and industrial sectors.
·
Convert Commercial Pipeline & Backlog: Deliver on our $2.5 million sales backlog and convert key opportunities within our $35 million commercial sales pipeline ($8.6 million in advanced stages), including integrated SIS, Hybrid, and Custom Engineered System deployments.
·
Advance High-Value Technical & Regulatory Pathways: Progress our FDA 510(k) medical device clearance submission, capitalize on the new EPA AgriMist label expansion in agricultural and food safety markets, and leverage 11 EU/UK regulatory authorizations to capture European cleanroom and life sciences demand.
·
Expand Defense & Institutional Sales: Scale distribution channels across defense and public health sectors by leveraging our Defense Logistics Agency (DLA) distribution authorization and expanding international partner networks across Europe, Canada, Latin America, and Asia.
Conference Call Information
TOMI will hold a conference call to discuss Second Quarter 2026 results at 4:30 p.m. ET today, August 14, 2026.
5
To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time and provide participant access code 709299 or request the "TOMI Environmental Solutions second quarter earnings call." International callers please dial (973) 528-0011. To access the live webcast or view the press release, please visit the Investor Relations section of the TOMI website or register at the following link:
https://www.webcaster5.com/Webcast/Page/2262/54403
A replay of the teleconference will be available until August 21, 2026, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use replay access code: 54403. A replay of the webcast will be available for at least 90 days on the company’s website, starting approximately one hour after the completion of the call.
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.
6
Forward-Looking Statements
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management's judgment, beliefs, current trends and anticipated business and market conditions. These forward-looking statements include, without limitation, statements regarding the proposed merger between TOMI Environmental Solutions, Inc. ("TOMI") and Carbonium Core, Inc. ("Carbonium"), including the anticipated timing and completion of the transaction, expected benefits to TOMI and its stockholders, anticipated growth opportunities, future business prospects, the commercialization and scaling of Carbonium's technology, anticipated financing activities, expected market demand for nuclear-grade graphite and other critical materials, and TOMI's expectations regarding future revenue growth, backlog conversion, business development initiatives, international expansion, operational performance and financial results, including the statements under the section entitled "Looking Ahead."
The proposed merger remains subject to the satisfaction or waiver of customary closing conditions, including, among other things, completion of contemplated financing activities, regulatory and other approvals, continued compliance with applicable Nasdaq requirements, and other conditions set forth in the definitive merger agreement. There can be no assurance that the transaction will be completed on the anticipated terms, within the expected timeframe, or at all.
Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such statements. These risks include, but are not limited to, risks related to the completion of the proposed merger; the ability of the combined company to successfully execute its business strategy; the commercialization, development and scalability of Carbonium's technology and operations; the ability to obtain necessary financing; changes in market demand, competitive conditions, regulatory developments or economic conditions; TOMI's ability to acquire new customers, expand sales, maintain growth, convert backlog and pipeline opportunities into revenue, and improve operating performance; reliance on a limited number of products for a significant portion of revenues; and other risks described in TOMI's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
The information provided in this press release is based on facts and circumstances known at the time of issuance. Actual results may differ materially from those anticipated due to a variety of factors, including those described above and other unknown or unpredictable factors. Although TOMI believes the expectations reflected in these forward-looking statements are reasonable, it cannot guarantee future results, levels of activity, performance or achievements. Readers are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements speak only as of the date of this press release, and TOMI undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.
The following represents our condensed consolidated balance sheets and statement of operations from our Quarterly Report on Form 10-Q for the three months ended June 30, 2026:
7
TOMI ENVIRONMENTAL SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
ASSETS
As of
June 30,
2026
As of
December 31,
2025
Current assets:
(Unaudited)
Cash and cash equivalents
$ 321,899
$ 87,775
Accounts receivable, net
1,890,105
689,153
Inventories, net (Note 3)
2,812,414
2,926,427
Vendor deposits (Note 4)
226,999
161,597
Prepaid expenses
229,338
322,114
Other current assets
49,113
-
Total current assets
5,529,868
4,187,066
Property and equipment, net (Note 5)
513,176
614,311
Other assets:
Intangible assets, net (Note 6)
1,349,262
1,351,164
Operating lease – right of use asset (Note 7)
280,026
322,089
Other assets
709,515
559,671
Total other assets
2,338,803
2,232,924
Total assets
$ 8,381,847
$ 7,034,301
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable
$ 1,603,561
$ 1,480,189
Accrued expenses and other current liabilities (Note 12)
1,525,401
860,703
Deferred revenue
431,100
424,032
Sale of future receipts, net of discount of $0 and $113,191 at June 30, 2026 and December 31, 2025, respectively (Note 11)
-
254,234
Current portion of long-term operating lease (Note 7)
151,421
143,672
Total current liabilities
3,711,483
3,162,830
Long-term liabilities:
Long-term operating lease, net of current portion (Note 7)
292,906
370,591
Convertible notes payable, net of discount of $185,978 and $222,624 at June 30, 2026 and December 31, 2025, respectively (Note 8)
2,949,022
2,912,376
Total long-term liabilities
3,241,928
3,282,967
Total liabilities
6,953,411
6,445,797
Commitments and contingencies (Notes 7, 8, 10 and 11)
-
-
Shareholders’ equity:
Cumulative convertible Series A preferred stock; par value $0.01 per share, 1,000,000 shares authorized; 21,250 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively (retroactively adjusted for the 1-for-3 reverse stock split - Note 9)
$ 213
$ 213
Cumulative convertible Series B preferred stock; $1,000 stated value; 7.5% cumulative dividend; 4,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025, respectively
-
-
Common stock; par value $0.01 per share, 250,000,000 shares authorized; 8,142,577 and 6,759,157 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively (retroactively adjusted for the 1-for-3 reverse stock split - Note 9)
81,425
67,591
Additional paid-in capital
60,591,729
58,572,686
Accumulated deficit
(59,244,931 )
(58,051,986 )
Total shareholders’ equity
1,428,436
588,504
Total liabilities and shareholders' equity
$ 8,381,847
$ 7,034,301
All share and per share amounts presented in these condensed consolidated financial statements have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split, effective July 20, 2026 (see Note 9), unless otherwise indicated.
The accompanying notes are an integral part of the condensed consolidated financial statements.
8
TOMI ENVIRONMENTAL SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
For the three months ended June 30,
For the six months ended June 30,
2026
2025
2026
2025
Sales, net
$ 2,246,909
$ 1,031,115
$ 3,901,136
$ 2,607,673
Cost of sales
861,603
353,991
1,684,054
978,804
Gross profit
1,385,306
677,124
2,217,082
1,628,869
Operating expenses:
Professional fees
$ 342,693
$ 183,874
$ 524,663
$ 403,190
Depreciation and amortization
50,080
69,238
102,948
137,780
Selling expenses
228,025
240,462
425,327
486,868
Research and development
38,052
84,106
94,872
128,686
Consulting fees
176,706
63,098
241,795
142,169
General and administrative
793,892
1,169,035
1,697,885
2,217,330
Total operating expenses
1,629,448
1,809,813
3,087,490
3,516,023
Loss from operations
(244,142 )
(1,132,689 )
(870,408 )
(1,887,154 )
Other income (expense):
Other income (Employee Retention Credit)
-
-
-
534,912
Interest income
486
1,421
516
84,311
Interest expense
(138,643 )
(106,248 )
(323,053 )
(225,178 )
Total other income (expense)
(138,157 )
(104,827 )
(322,537 )
394,045
Loss before income taxes
(382,299 )
(1,237,516 )
(1,192,945 )
(1,493,109 )
Provision for income taxes (Note 13)
-
-
-
-
Net loss
$ (382,299 )
$ (1,237,516 )
$ (1,192,945 )
$ (1,493,109 )
Net loss per common share:
Basic
$ (0.05 )
$ (0.19 )
$ (0.17 )
$ (0.22 )
Diluted
$ (0.05 )
$ (0.19 )
$ (0.17 )
$ (0.22 )
Basic weighted average common shares outstanding
7,596,869
6,682,504
7,204,206
6,677,149
Diluted weighted average common shares outstanding
7,596,869
6,682,504
7,204,206
6,677,149
All share and per share amounts presented in these condensed consolidated financial statements have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split, effective July 20, 2026 (see Note 9), unless otherwise indicated.
The accompanying notes are an integral part of the condensed consolidated financial statements.
9
GRAPHIC
GRAPHIC
Filename: tomz_ex991img1.jpg · Sequence: 8
Binary file (5143 bytes)
Download tomz_ex991img1.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 10
v3.26.1
Cover
Aug. 14, 2026
Cover [Abstract]
Entity Registrant Name
TOMI ENVIRONMENTAL SOLUTIONS, INC.
Entity Central Index Key
0000314227
Document Type
8-K
Amendment Flag
false
Entity Emerging Growth Company
false
Document Period End Date
Aug. 14, 2026
Entity File Number
000-09908
Entity Incorporation State Country Code
FL
Entity Tax Identification Number
59-1947988
Entity Address Address Line 1
8430 Spires Way
Entity Address State Or Province
MD
Entity Address Postal Zip Code
21701
City Area Code
800
Written Communications
false
Soliciting Material
false
Pre Commencement Tender Offer
false
Pre Commencement Issuer Tender Offer
false
Local Phone Number
525-1698
Security 12b Title
Common Stock, $0.01 par value per share
Trading Symbol
TOMZ
Security Exchange Name
NASDAQ
Entity Address City Or Town
Frederick
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration